Loading
Latest filing published 09 Aug 2022 for RVL Pharmaceuticals plc, €12.2M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Avista Healthcare Partners, L.P. has a single filing on record, published on 9 August 2022: an open-market purchase of €12.2M in RVL Pharmaceuticals plc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by David F. Burgstahler, counted once
1 of 0 declarations